Novonix (NVNXF) Shares Outstanding (Diluted Average) (2021 - 2024)

Novonix has reported Shares Outstanding (Diluted Average) for 4 years, with the latest figure at $496.9 billion in Q4 2024.

• For the quarter ending Q4 2024, Shares Outstanding (Diluted Average) rose 1.93% year-over-year to $496.9 billion; the trailing twelve-month figure through Dec 2024 stood at $496.9 billion (up 1.93% YoY), and the FY2025 full-year result was $447.6 million, down 99.91% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2024 stood at $496.9 billion, up from $487.5 billion in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $496.9 billion in Q4 2024, with the low at $282.1 million in Q2 2021.
• Historically, Shares Outstanding (Diluted Average) has averaged $245.3 billion across 4 years, with a median of $243.5 billion in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) soared 150444.64% — and 2023, when it advanced 0.18%.
• Novonix's Shares Outstanding (Diluted Average) stood at $323.2 million in 2021, then soared by 150444.64% to $486.6 billion in 2022, then gained by 0.18% to $487.5 billion in 2023, then gained by 1.93% to $496.9 billion in 2024.
• The last three Shares Outstanding (Diluted Average) figures came in at $496.9 billion (Q4 2024), $487.5 billion (Q4 2023), and $486.6 billion (Q4 2022), per Business Quant data.